Cargando…

Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?

Rapid adoption of new diagnostic tools, parallel process of research and implementation, decentralisation of services, the use of personal protective equipment, as well as strong partnership and collaboration, could strengthen the fight against COVID-19 https://bit.ly/2XupDNe

Detalles Bibliográficos
Autores principales: Ndjeka, Norbert, Conradie, Francesca, Meintjes, Graeme, Reuter, Anja, Hughes, Jennifer, Padanilam, Xavier, Ismail, Nazir, Kock, Yulene, Master, Iqbal, Romero, Rodolfo, te Riele, Julian, Enwerem, Martin, Ferreira, Hannetjie, Maartens, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257618/
https://www.ncbi.nlm.nih.gov/pubmed/32471936
http://dx.doi.org/10.1183/13993003.01369-2020
_version_ 1783540068339679232
author Ndjeka, Norbert
Conradie, Francesca
Meintjes, Graeme
Reuter, Anja
Hughes, Jennifer
Padanilam, Xavier
Ismail, Nazir
Kock, Yulene
Master, Iqbal
Romero, Rodolfo
te Riele, Julian
Enwerem, Martin
Ferreira, Hannetjie
Maartens, Gary
author_facet Ndjeka, Norbert
Conradie, Francesca
Meintjes, Graeme
Reuter, Anja
Hughes, Jennifer
Padanilam, Xavier
Ismail, Nazir
Kock, Yulene
Master, Iqbal
Romero, Rodolfo
te Riele, Julian
Enwerem, Martin
Ferreira, Hannetjie
Maartens, Gary
author_sort Ndjeka, Norbert
collection PubMed
description Rapid adoption of new diagnostic tools, parallel process of research and implementation, decentralisation of services, the use of personal protective equipment, as well as strong partnership and collaboration, could strengthen the fight against COVID-19 https://bit.ly/2XupDNe
format Online
Article
Text
id pubmed-7257618
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-72576182020-06-03 Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis? Ndjeka, Norbert Conradie, Francesca Meintjes, Graeme Reuter, Anja Hughes, Jennifer Padanilam, Xavier Ismail, Nazir Kock, Yulene Master, Iqbal Romero, Rodolfo te Riele, Julian Enwerem, Martin Ferreira, Hannetjie Maartens, Gary Eur Respir J Agora Rapid adoption of new diagnostic tools, parallel process of research and implementation, decentralisation of services, the use of personal protective equipment, as well as strong partnership and collaboration, could strengthen the fight against COVID-19 https://bit.ly/2XupDNe European Respiratory Society 2020-07-23 /pmc/articles/PMC7257618/ /pubmed/32471936 http://dx.doi.org/10.1183/13993003.01369-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Agora
Ndjeka, Norbert
Conradie, Francesca
Meintjes, Graeme
Reuter, Anja
Hughes, Jennifer
Padanilam, Xavier
Ismail, Nazir
Kock, Yulene
Master, Iqbal
Romero, Rodolfo
te Riele, Julian
Enwerem, Martin
Ferreira, Hannetjie
Maartens, Gary
Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
title Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
title_full Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
title_fullStr Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
title_full_unstemmed Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
title_short Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
title_sort responding to sars-cov-2 in south africa: what can we learn from drug-resistant tuberculosis?
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257618/
https://www.ncbi.nlm.nih.gov/pubmed/32471936
http://dx.doi.org/10.1183/13993003.01369-2020
work_keys_str_mv AT ndjekanorbert respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT conradiefrancesca respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT meintjesgraeme respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT reuteranja respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT hughesjennifer respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT padanilamxavier respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT ismailnazir respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT kockyulene respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT masteriqbal respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT romerorodolfo respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT terielejulian respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT enweremmartin respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT ferreirahannetjie respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis
AT maartensgary respondingtosarscov2insouthafricawhatcanwelearnfromdrugresistanttuberculosis